Flexible Hybrid Jobs in Philadelphia

Showing 5 results

Sort by:

Director GHEOR
PhiladelphiaNegotiable

Director of Global Health Economics and Outcomes Research Location: Philadelphia, PA OR Boston, MA (Hybrid- 3 days onsight/ week) EPM Scientific is partnered with a rapidly growing, Commercial-Stage Biopharmaceutical company to hire a Director of GHEOR. Our client is seeking a health economics & outcomes research expert to drive evidence generati...

Marketing Manager
PhiladelphiaUS$90000 - US$120000 per annum

Marketing Manager Location: Greater Philadelphia - Hybrid About the Company: Come join a rapidly growing pharma based in the Greater Philadelphia area. With a strong commitment to patient care, this organization is dedicated to developing and commercializing innovative therapies that make a meaningful impact on lives.Role Overview: They are seekin...

Senior Director Biostatistics Oncology
philadelphiaUS$260000 - US$320000 per year

Senior Director, Biostatistics - OncologyLocation: Pennsylvania Department: Biostatistics Reports to: VP/Head of Biostatistics Position SummaryThe Senior Director, Biostatistics - Oncology will serve as a strategic leader responsible for driving statistical excellence across the oncology portfolio. This role provides scientific and operational lea...

Elevate your career

Take the first step toward your next opportunity - submit your resume and get started today.

Register resume
Selby Jennings Start Your Career In Recruitment
Director GHEOR
PhiladelphiaNegotiable

Director of Global Health Economics and Outcomes Research Location: Philadelphia, PA OR Boston, MA (Hybrid- 3 days onsight/ week) EPM Scientific is partnered with a rapidly growing, Commercial-Stage Biopharmaceutical company to hire a Director of GHEOR. Our client is seeking a health economics & outcomes research expert to drive evidence generati...

Sr. Clinical Scientist
PhiladelphiaUS$150000 - US$180000 per year

Sr. Clinical ScientistGreater Philadelphia Area (Hybrid 2 days on-site)Compensation: $130,000-180,000 Company Summary: This late‑stage biotechnology company is developing a first‑in‑class therapeutic platform for neurodegenerative diseases. Its lead candidate is uniquely designed to target multiple neurotoxic proteins simultaneously, representing a...